Product Code Database
Example Keywords: tetris -stocking $42
barcode-scavenger
   » » Wiki: Argatroban
Tag Wiki 'Argatroban'.
Tag

Popular Book Products

They often take pride in not being diverted by impediments such as legal restrictions. Incompetent suitors Clinical features The stalkers who fall into the incompetent typology cover a wide range of individuals, many of whose behaviours and�...

Mid-fifth-century Athens saw the development of the Athenian empire, the radicalization of Athenian democracy through the empowerment of poorer citizens, the adornment of the city through a massive and expensive building program, the classical age of Athen..

This 2003 volume investigates written communication before and after the introduction of printing in England. The Uses Of Script And Print, 1300-1700 available on November 13 2015 from Indigo for 127.77

No Synopsis Available Twisted Entities: Contemporary Polish Art / Zeitgenossische Polnische Kumst available on November 04 2023 from BiggerBooks for 43.0

Argatroban is an that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the US Food and Drug Administration (FDA) for prophylaxis or treatment of in people with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during in people who have HIT or are at risk for developing it. In 2012, it was approved by the UK Medicines and Healthcare products Regulatory Agency for anticoagulation in people with heparin-induced thrombocytopenia Type II (HIT) who require parenteral antithrombotic therapy.

Argatroban is given intravenously and drug plasma concentrations reach steady state in 1–3 hours. Argatroban is metabolized in the and has a of about 50 minutes. It is monitored by PTT. Because of its hepatic metabolism, it may be used in patients with renal dysfunction. (This is in contrast to , a direct thrombin inhibitor that is primarily renally cleared).


Transitioning to warfarin in individuals with heparin-induced thrombocytopenia
Argatroban is used as an anticoagulant in individuals with thrombosis and heparin-induced thrombocytopenia. Often these individuals require long-term anticoagulation. If is chosen as the long-term anticoagulant, this poses particular challenges due to the falsely elevated and INR caused by argatroban. The combination of argatroban and warfarin may raise the INR to greater than 5.0 without a significant increased risk of bleeding complications. One solution to this problem is to measure the chromogenic factor X level. A level < 40–45% typically indicates that the INR will be therapeutic (2–3) when the argatroban is discontinued.

Page 1 of 1
1
Post Comment
Font Size...
Font Family...
Font Format...

Page 1 of 1
1

Account

Social:
Pages:  ..   .. 
Items:  .. 

Navigation

General: Atom Feed Atom Feed  .. 
Help:  ..   .. 
Category:  ..   .. 
Media:  ..   .. 
Posts:  ..   ..   .. 

Statistics

Page:  .. 
Summary:  .. 
1 Tags
10/10 Page Rank
5 Page Refs